Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.

Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.

The high schooler was studying cancer biomarkers in a George Mason University lab when her familial experiences with Lyme disease sparked an idea.

How close are liquid biopsies to replacing current diagnostics?

The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”

Two teams report molecular diagnosis rates of 25 percent sequencing separate sets of patients with undiagnosed, suspected genetic conditions.

Nanoparticle-producing bacteria may simplify the diagnosis of cancer and other medical conditions.

In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.

Antibody barcoding allows scientists and clinicians to analyze protein expression in small amounts of cancer tissue.